NEJM Interviews

NEJM Group
  • 5,0 (1)
  • MEDIZIN
  • ZWEIWÖCHENTLICH
NEJM Interviews

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

  1. VOR 5 TAGEN

    NEJM Interview: Carmel Shachar on modernizing labor laws and strike regulations to support physicians, patients, and hospitals.

    Carmel Shachar is an assistant clinical professor of law and faculty director of the Health Law and Policy Clinic at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Ramesh, C. Shachar, and H. Yu. Striking a Balance — Advancing Physician Collective-Bargaining Rights and Patient Protections. N Engl J Med 2025;392:209-211.

    9 Min.

  2. 8. JAN.

    NEJM Interview: David Velasquez on care for older, low-income adults who can’t enroll in Medicare or Medicaid because they’re undocumented immigrants.

    David Velasquez is an internal medicine resident physician at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.E. Velasquez, E.T. Roberts, and J.F. Figueroa. The Plight of “Dual Noneligible” People in the United States. N Engl J Med 2025;392:105-107.

    12 Min.

  3. 1. JAN.

    NEJM Interview: Joey Mattingly on providing widespread access to HCV treatment at the lowest possible price.

    Joey Mattingly is an associate professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.S. Tu, S. Kottilil, and T.J. Mattingly II. Leveraging Old Hepatitis C Therapies. N Engl J Med 2025;392:1-4.

    12 Min.

  4. 18.12.2024

    NEJM Interview: Lauren Schiff on the need for improved training and increased comfort in treating autistic people.

    Lauren Schiff is an associate professor of Ob/Gyn and a minimally invasive gynecologic surgeon at the University of North Carolina School of Medicine and the associate chief medical officer for quality and safety at UNC Hospitals. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.D. Schiff, A.O.D. Hester, and T. Benevides. Providing Effective Medical Care to Autistic People. N Engl J Med 2024;391:2281-2283.

    13 Min.

  5. 11.12.2024

    NEJM Interview: Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals.

    Bindu Kanapuru is a hematologist–oncologist physician in the Office of Oncologic Diseases at the FDA’s Center for Drug Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B. Kanapuru and Others. Autopsy of a Drug Withdrawal — The Case of Melphalan Flufenamide. N Engl J Med 2024;391:2177-2179.

    9 Min.

  6. 04.12.2024

    NEJM Interview: Karen Joynt Maddox on the Transforming Episode Accountability Model recently announced by CMS.

    Karen Joynt Maddox is an associate professor of medicine at Washington University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.A. Shashikumar, A.M. Ryan, and K.E. Joynt Maddox. Medicare’s New Mandatory Bundled-Payment Program — Are We Ready for TEAM? N Engl J Med 2024;391:2065-2067.

    11 Min.

  7. 27.11.2024

    NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer research and care practices.

    Andrew Hantel is an assistant professor of medicine at Harvard Medical School and a faculty member in the Divisions of Leukemia and Population Sciences at Dana-Farber Cancer Institute and at the HMS Center for Bioethics. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Hantel and Others. The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care. N Engl J Med 2024;391:1969-1972.

    13 Min.

  8. 20.11.2024

    NEJM Interview: Benjamin Rome on the results of the initial round of drug-price negotiation under the Inflation Reduction Act.

    Benjamin Rome is a physician and health policy researcher at Brigham and Women’s Hospital and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.N. Rome, A.S. Kesselheim, and W.B. Feldman. Medicare’s First Round of Drug-Price Negotiation — Measuring Success. N Engl J Med 2024;391:1865-1868.

    10 Min.
Alle anzeigen (867)

Info

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Informationen

  • Kanal
    NEJM Group
  • Erstellt von
    NEJM Group
  • Jahre aktiv
    2006 - 2025
  • Folgen
    867
  • Bewertung
    Unbedenklich
  • Copyright
    © Copyright 2025 Massachusetts Medical Society
  • Sendungswebsite
    NEJM Interviews

Mehr von NEJM Group

Das gefällt dir vielleicht auch

Melde dich an, um anstößige Folgen anzuhören.

Bleib auf dem Laufenden mit dieser Sendung

Melde dich an oder registriere dich, um Sendungen zu folgen, Folgen zu sichern und die neusten Updates zu erhalten.
Wähle ein Land oder eine Region aus

Afrika, Naher Osten und Indien

Asien/Pazifik

Europa

Lateinamerika und Karibik

USA und Kanada